Search Results - "Katonova, Alzbeta"

Plasminogen activator inhibitor‐1 serum levels in frontotemporal lobar degeneration by Angelucci, Francesco, Veverova, Katerina, Katonová, Alžbeta, Vyhnalek, Martin, Hort, Jakub

“…Plasminogen activator inhibitor‐1 (PAI‐1) impedes brain plasmin synthesis. Reduced plasmin activity facilitates cumulation of amyloid beta (Aβ) in Alzheimer's…”
Get full text

Effect of a Vegan Diet on Alzheimer's Disease by Katonova, Alzbeta, Sheardova, Katerina, Amlerova, Jana, Angelucci, Francesco, Hort, Jakub

“…There is evidence indicating that a vegan diet could be beneficial in the prevention of neurodegenerative disorders, including Alzheimer's disease (AD). The…”
Get full text

Alzheimer’s Disease Severity Is Associated with an Imbalance in Serum Levels of Enzymes Regulating Plasmin Synthesis by Angelucci, Francesco, Veverova, Katerina, Katonová, Alžbeta, Piendel, Lydia, Vyhnalek, Martin, Hort, Jakub

“…Alzheimer’s disease (AD) is a central nervous system (CNS) disease characterized by loss of memory, cognitive functions, and neurodegeneration. Plasmin is an…”
Get full text

CSF neurogranin levels as a biomarker in Alzheimer's disease and frontotemporal lobar degeneration: a cross-sectional analysis by Jurasova, Vanesa, Andel, Ross, Katonova, Alzbeta, Veverova, Katerina, Zuntychova, Terezie, Horakova, Hana, Vyhnalek, Martin, Kolarova, Tereza, Matoska, Vaclav, Blennow, Kaj, Hort, Jakub

“…There is initial evidence suggesting that biomarker neurogranin (Ng) may distinguish Alzheimer's disease (AD) from other neurodegenerative diseases. Therefore,…”
Get full text

Differentiation of clinically diagnosed patients with aMCI and dementia from cognitively unimpaired older adults using plasma and serum p‐tau 181 and NfL by Jurasova, Vanesa, Veverova, Katerina, Angelucci, Francesco, Katonova, Alzbeta, Vyhnalek, Martin, Andel, Ross, Hort, Jakub

“…Background Blood‐based biomarkers give the possibility of having a less invasive, more acceptable to patients, and cost‐ and time‐efficient screening tool…”
Get full text

The molar ratio between PAI‐1 and BDNF is increased in Alzheimer’s disease patients with full dementia and negatively correlates with MMSE score by Angelucci, Francesco, Veverova, Katerina, Katonova, Alzbeta, Jurasova, Vanesa, Vyhnalek, Martin, Andel, Ross, Hort, Jakub, Sheardova, Katerina

“…Background In a previous study, we demonstrated that the enzyme plasminogen activator inhibitor‐1 (PAI‐1), which inhibits plasmin synthesis in the central…”
Get full text

Levels of Mitophagy Biomarkers Differ Between Individuals With Alzheimer’s disease and Frontotemporal Lobar Degeneration by Katonova, Alzbeta, Veverova, Katerina, Horakova, Hana, Angelucci, Francesco, Laczó, Jan, Hort, Jakub, Shi, Liu, Fang, Evandro Fei, Vyhnalek, Martin

“…Background Reduced removal of dysfunctional mitochondria has been implicated in the pathogenesis of many neurodegenerative diseases, including Alzheimer’s…”
Get full text

Mitophagy biomarkers are changed in the continuum of Alzheimer’s disease by Veverova, Katerina, Katonova, Alzbeta, Horakova, Hana, Angelucci, Francesco, Laczó, Jan, Hort, Jakub, Shi, Liu, Fang, Evandro Fei, Vyhnalek, Martin

“…Background Autophagy is a cellular self “garbage clearance ”system through which cells eliminate and recycle dysfunctional cytoplasmatic components, such as…”
Get full text

Serum PAI-1/BDNF Ratio Is Increased in Alzheimer’s Disease and Correlates with Disease Severity by Angelucci, Francesco, Veverova, Katerina, Katonová, Alžbeta, Vyhnalek, Martin, Hort, Jakub

“…We previously demonstrated that serum levels of plasminogen activator inhibitor-1 (PAI-1), which inhibits both the tissue plasminogen activator (tPA) and…”
Get full text

Alterations of human CSF and serum-based mitophagy biomarkers in the continuum of Alzheimer disease by Veverová, Kateřina, Laczó, Jan, Katonová, Alžběta, Horáková, Hana, Matušková, Veronika, Angelucci, Francesco, Laczó, Martina, Nedelská, Zuzana, Hort, Jakub, Wang, He-Ling, Zhang, Jianying, Shi, Liu, Fei Fang, Evandro, Vyhnálek, Martin

“…Defective mitophagy is consistently found in postmortem brain and iPSC-derived neurons from Alzheimer disease (AD) patients. However, there is a lack of…”
Get full text